相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Still's disease as biphasic disorder Current knowledge on pathogenesis and novel treatment approaches
D. Foell et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2020)
A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis
Lauren A. Henderson
ARTHRITIS & RHEUMATOLOGY (2019)
Cyclosporine for Systemic Onset Juvenile Idiopathic Arthritis: Current Stand and Future Directions
Narendra Kumar Bagri
INDIAN JOURNAL OF PEDIATRICS (2019)
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
Alberto Martini et al.
JOURNAL OF RHEUMATOLOGY (2019)
Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis
Benedetta Saccomanno et al.
JOURNAL OF RHEUMATOLOGY (2019)
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
Jurgen Sota et al.
CLINICAL RHEUMATOLOGY (2018)
Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST)
Peter A. Nigrovic et al.
CLINICAL TRIALS (2018)
IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry)
M. Bielak et al.
PEDIATRIC RHEUMATOLOGY (2018)
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany
Claas H. Hinze et al.
PEDIATRIC RHEUMATOLOGY (2018)
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
Natasa Toplak et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
Nicolino Ruperto et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition
Sriharsha Grevich et al.
ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS (2017)
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
Gerd Horneff et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials
Simon Tarp et al.
RHEUMATOLOGY (2016)
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
Alexei A. Grom et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013
Jens Klotsche et al.
Arthritis & Rheumatology (2016)
Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever
Faekah Gohar et al.
Arthritis & Rheumatology (2016)
Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches
Normi Bruck et al.
CLINICAL IMMUNOLOGY (2015)
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
Linda Rossi-Semerano et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
A. Woerner et al.
RMD OPEN (2015)
Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course
Boris Huegle et al.
PEDIATRIC RHEUMATOLOGY (2014)
Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2012)
Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis
Gregor Dueckers et al.
CLINICAL IMMUNOLOGY (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Application of the Yamaguchi criteria for classification of suspected systemic juvenile idiopathic arthritis (sJIA)
Sharath Kumar et al.
PEDIATRIC RHEUMATOLOGY (2012)
Systemic Onset Juvenile Idiopathic Arthritis - At the Borderline between Autoinflammation and Autoimmunity
J. -P. Haas
AKTUELLE RHEUMATOLOGIE (2011)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series
Peter A. Nigrovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Translational research network and patient registry for auto-inflammatory diseases
Elke Lainka et al.
RHEUMATOLOGY (2011)
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2008)
Predictors of disease course and remission in systemic juvenile idiopathic arthritis - Significance of early clinical and laboratory features
D. Singh-Grewal et al.
ARTHRITIS AND RHEUMATISM (2006)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
分享论文
